Science Applications International Corp SAIC

IndustrialsSoftware & IT ServicesUnited States of America

Last close 152.91 USD on Nov 2, 2026, +54.0% year to date

Quant rating

Quant rating A Rank 22 of 486 in Industrials

Growth D 376 of 486
Valuation B 84 of 486
Quality B 122 of 486
Revisions B 102 of 486
Momentum A 11 of 486

Wall Street consensus Hold (2.73)Average target 131.55 USD −14.0%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 6.4B
Enterprise value: 8.8B
52-week range: 81.12 – 153.48
3-year range: 81.12 – 154.10
Dividend yield: 0.97%
Beta (5 years): 0.26
Shares outstanding: 41.9M
Next earnings: Dec 2, 2026

About the company

Science Applications International Corporation is a technology integrator providing full life cycle services and solutions in the technical, engineering, mission and enterprise information technology (IT) markets. The Company's portfolio of offerings across the defense, space, civilian and intelligence markets include secure solutions in mission IT, enterprise IT, engineering services and professional services. It integrates emerging technology securely into mission critical operations that modernize and enable critical national imperatives, including IT modernization, digital engineering, artificial intelligence and ground vehicle support. Its segments include Defense & Intelligence, and Civilian. Defense & Intelligence segment provides a diverse portfolio of national security solutions to the Department of Defense and Intelligence Community of the United States Government. Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

Growth and profitability fiscal year ends January 31

Growth and profitability by fiscal year
	2026	2025	2024	2023	2022	5Y avg
Revenue (mil)	7,262	7,479	7,444	7,704	7,394	–
Revenue growth	−2.9%	0.5%	−3.4%	4.2%	4.8%	0.6%
EPS (basic, normalized)	10.75	9.13	7.88	7.55	7.27	–
EPS growth	17.7%	15.9%	4.4%	3.9%	–	–
Gross margin	12.0%	11.9%	11.7%	11.5%	11.6%	11.8%
Net margin	4.9%	4.8%	6.4%	3.9%	3.7%	4.8%
ROE	23.3%	21.5%	27.4%	18.1%	17.5%	21.6%

Balance sheet, last quarter
Cash & short-term investments (mil)	126
Current ratio	1.20x
Long-term debt (mil)	2,452
Net debt (mil)	2,359
Total equity (mil)	1,436
Net debt / equity	1.64x
Net debt / EBITDA	3.33x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2026 actual	7,262	−2.9%	1.2x	708	+2.4%	12.4x	10.75	+17.7%	14.2x
2027	7,302	+0.5%	1.2x	761	+7.5%	11.5x	10.79	+0.4%	14.2x
2028	7,395	+1.3%	1.2x	770	+1.2%	11.4x	11.49	+6.4%	13.3x
2029	7,567	+2.3%	1.2x	809	+5.0%	10.8x	13.08	+13.8%	11.7x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2027	7,302	+0.1%	+1.6%	+2.6%	10.79	0.0%	+6.1%	+12.0%
2028	7,395	0.0%	+1.7%	+2.2%	11.49	0.0%	+4.4%	+6.4%
2029	7,567	+0.1%	+1.9%	+3.1%	13.08	0.0%	+4.8%	+6.9%

Earnings surprises EPS beat in 4 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Sales reported (mil)	1,847	1,818	1,976	1,838	1,877	1,769	1,866	1,750	1,906	1,880
Sales mean (mil)	1,844	1,787	1,934	1,811	1,866	1,863	1,890	1,758	1,820	1,766
Surprise	+0.2%	+1.7%	+2.2%	+1.5%	+0.6%	−5.1%	−1.3%	−0.5%	+4.7%	+6.4%
EPS reported	1.92	2.05	2.61	2.57	1.92	3.63	2.58	2.62	3.23	3.01
EPS mean	1.92	1.86	2.17	2.08	2.13	2.24	2.15	1.93	2.28	2.31
Surprise	−0.1%	+10.5%	+20.5%	+23.3%	−9.8%	+62.3%	+20.3%	+35.5%	+41.8%	+30.4%

Peer comparison Software & IT Services

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
SAIC Science Applications International Corp	6.4B	3.33x	4.9%	4.47x	14.2x	13.3x	11.5x	11.4x
IBM International Business Machines Corp	238.7B	2.78x	17.4%	6.71x	20.3x	19.0x	14.4x	13.5x
ACN Accenture PLC	154.1B	−0.07x	11.3%	4.93x	17.8x	16.4x	10.3x	9.7x
LDOS Leidos Holdings, Inc.	18.1B	2.20x	8.4%	3.42x	11.6x	11.7x	9.5x	9.7x
CACI CACI International Inc	15.1B	3.88x	5.6%	3.25x	20.1x	17.4x	14.0x	12.9x
BAH Booz Allen Hamilton Holding Corporation	10.4B	3.32x	7.5%	8.43x	13.3x	13.0x	11.4x	10.8x
Mean		2.57x	9.2%	5.20x	16.2x	15.1x	11.9x	11.3x
Median		3.05x	8.0%	4.70x	16.0x	14.9x	11.5x	11.1x

Technical analysis

1M+22.4%
3M+30.9%
1Y+65.4%
3Y+44.3%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Science Applications International Corp, fiscal years, most recent first
	2026	2025	2024	2023	2022	2021
Total revenue	7,262	7,479	7,444	7,704	7,394	7,056
Cost of revenue	6,390	6,587	6,572	6,816	6,535	6,264
Gross profit	872	892	872	888	859	792
Selling, general & administrative expenses	325	319	346	355	338	341
Research & development	13.0	12.0	4.0	1.0	4.0	6.0
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	12.0	8.0	−216	31.0	58.0	59.0
Other operating expenses	1.0	−10.0	−3.0	0	−3.0	−4.0
Operating income	521	563	741	501	462	390
Net interest income (expense)	−128	−126	−120	−120	−105	−122
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	−6.0	−9.0	−1.0	−6.0	1.0	3.0
Net income before taxes	387	428	620	375	358	271
Provision for taxes	29.0	66.0	143	72.0	79.0	60.0
Minority interest	–	0	0	−3.0	−2.0	−2.0
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	358	362	477	300	277	209
Extraordinary items	–	–	–	–	–	–
Net income	358	362	477	300	277	209
EBIT, normalized	566	566	519	526	519	446
EBITDA, normalized	715	706	661	683	684	625
Basic EPS, normalized	10.75	9.13	7.88	7.55	7.27	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Science Applications International Corp, fiscal years, most recent first
	2026	2025	2024	2023	2022	2021
Assets
Cash & short-term investments	182	56.0	94.0	109	106	171
Receivables	853	1,000	914	936	1,015	962
Total inventory	–	–	3.0	71.0	64.0	78.0
Prepaid expenses	122	78.0	93.0	58.0	57.0	56.0
Other current assets	22.0	20.0	27.0	23.0	21.0	22.0
Total current assets	1,179	1,154	1,131	1,197	1,263	1,289
Property, plant & equipment	303	268	243	250	309	344
Goodwill	2,944	2,851	2,851	2,911	2,913	2,787
Intangibles	761	779	894	1,009	1,132	1,138
Long-term investments	–	36.0	32.0	28.0	28.0	–
Note receivable	41.0	44.0	14.0	15.0	17.0	18.0
Other long-term assets	126	114	149	133	84.0	147
Total assets	5,354	5,246	5,314	5,543	5,746	5,723
Liabilities
Accounts payable	500	631	567	624	612	517
Payable/accrued	–	–	–	–	–	–
Accrued expenses	422	414	461	423	537	608
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	19.0	313	77.0	31.0	148	68.0
Other current liabilities	41.0	38.0	53.0	48.0	55.0	82.0
Total current liabilities	982	1,396	1,158	1,126	1,352	1,275
Long-term debt	2,468	1,907	2,022	2,343	2,370	2,447
Minority interest	–	–	0	10.0	10.0	10.0
Other liabilities	404	366	349	370	395	449
Total liabilities	3,854	3,669	3,529	3,849	4,127	4,181
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	0	0	0	0	0	0
Additional paid-in capital	0	0	337	637	838	1,004
Retained earnings (accumulated deficit)	1,492	1,565	1,432	1,035	818	627
Treasury stock	–	–	–	–	–	–
Other equity	8.0	12.0	16.0	22.0	−37.0	−89.0
Total equity	1,500	1,577	1,785	1,694	1,619	1,542
Total liabilities & shareholders' equity	5,354	5,246	5,314	5,543	5,746	5,723

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Science Applications International Corp, fiscal years, most recent first
	2026	2025	2024	2023	2022	2021
Operating activities
Net income	358	362	477	303	279	211
Depreciation, depletion & amortization	149	140	142	157	165	179
Deferred taxes	81.0	−3.0	−17.0	−17.0	59.0	12.0
Non-cash items	65.0	46.0	−185	47.0	36.0	60.0
Changes in working capital	−44.0	−51.0	−21.0	42.0	−21.0	293
Cash from operations	609	494	396	532	518	755
Investing activities
Capital expenditures	−32.0	−36.0	−27.0	−25.0	−36.0	−46.0
Other investing cash flows	−216	1.0	341	−11.0	−256	−1,185
Cash from investing	−248	−35.0	314	−36.0	−292	−1,231
Financing activities
Financing cash flow items	−13.0	−3.0	0	−9.0	−2.0	−29.0
Cash dividends paid	−70.0	−75.0	−79.0	−83.0	−86.0	−87.0
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−152	−420	−646	−401	−213	580
Cash from financing	−235	−498	−725	−493	−301	464
Foreign exchange effects	–	–	–	–	–	–
Net change in cash	126	−39.0	−15.0	3.0	−75.0	−12.0
Free cash flow	577	458	369	507	482	709

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.